Intravenous Tocilizumab versus Standard of Care in the Treatment of Severe and Critical COVID-19-related Pneumonia: A Single Center, Double-blind, Placebo Controlled, Phase 3 Trial . Acta Med Philipp [Internet]. 2024 Apr. 15 [cited 2025 Apr. 24];58(6). Available from: https://actamedicaphilippina.upm.edu.ph/index.php/acta/article/view/6175